Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition

Autor: Anusha Kamesh, Austen J. Milnerwood, Chelsie A Kadgien
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Patch-Clamp Techniques
Parkinson's disease
Vesicular Transport Proteins
Protein traffic
Knock-in mouse
Mice
0302 clinical medicine
Protein Interaction Mapping
Gene Knock-In Techniques
Cells
Cultured

0303 health sciences
Chemistry
Miniature Postsynaptic Potentials
Neurodegeneration
Glutamate receptor
Parkinson Disease
LRRK2
Recombinant Proteins
Cell biology
Gain of Function Mutation
Retromer
NMDA receptor
Glutamatergic synapse
Glutamate
Protein Binding
Mutation
Missense

Glutamic Acid
Nerve Tissue Proteins
Endosomes
AMPA receptor
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
03 medical and health sciences
Cellular and Molecular Neuroscience
Neurotransmitter receptor
medicine
Animals
Point Mutation
Receptors
AMPA

Synaptic transmission
Kinase activity
RC346-429
Molecular Biology
030304 developmental biology
Research
Dendrites
medicine.disease
nervous system diseases
Mice
Inbred C57BL

NMDA
rab GTP-Binding Proteins
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
Dopamine Receptor
Synapses
Neurology. Diseases of the nervous system
030217 neurology & neurosurgery
Zdroj: Molecular Brain, Vol 14, Iss 1, Pp 1-20 (2021)
Molecular Brain
ISSN: 1756-6606
Popis: Vacuolar protein sorting 35 (VPS35) regulates neurotransmitter receptor recycling from endosomes. A missense mutation (D620N) in VPS35 leads to autosomal-dominant, late-onset Parkinson’s disease. Here, we study the basic neurobiology of VPS35 and Parkinson’s disease mutation effects in the D620N knock-in mouse and the effect of leucine-rich repeat kinase 2 (LRRK2) inhibition on synaptic phenotypes. The study was conducted using a VPS35 D620N knock-in mouse that expresses VPS35 at endogenous levels. Protein levels, phosphorylation states, and binding ratios in brain lysates from knock-in mice and wild-type littermates were assayed by co-immunoprecipitation and western blot. Dendritic protein co-localization, AMPA receptor surface expression, synapse density, and glutamatergic synapse activity in primary cortical cultures from knock-in and wild-type littermates were assayed using immunocytochemistry and whole-cell patch clamp electrophysiology. In brain tissue, we confirm VPS35 forms complexes with LRRK2 and AMPA-type glutamate receptor GluA1 subunits, in addition to NMDA-type glutamate receptor GluN1 subunits and D2-type dopamine receptors. Receptor and LRRK2 binding was unaltered in D620N knock-in mice, but we confirm the mutation results in reduced binding of VPS35 with WASH complex member FAM21, and increases phosphorylation of the LRRK2 kinase substrate Rab10, which is reversed by LRRK2 kinase inhibition in vivo. In cultured cortical neurons from knock-in mice, pRab10 is also increased, and reversed by LRRK2 inhibition. The mutation also results in increased endosomal recycling protein cluster density (VPS35-FAM21 co-clusters and Rab11 clusters), glutamate transmission, and GluA1 surface expression. LRRK2 kinase inhibition, which reversed Rab10 hyper-phosphorylation, did not rescue elevated glutamate release or surface GluA1 expression in knock-in neurons, but did alter AMPAR traffic in wild-type cells. The results improve our understanding of the cell biology of VPS35, and the consequences of the D620N mutation in developing neuronal networks. Together the data support a chronic synaptopathy model for latent neurodegeneration, providing phenotypes and candidate pathophysiological stresses that may drive eventual transition to late-stage parkinsonism in VPS35 PD. The study demonstrates the VPS35 mutation has effects that are independent of ongoing LRRK2 kinase activity, and that LRRK2 kinase inhibition alters basal physiology of glutamate synapses in vitro. Supplementary Information The online version contains supplementary material available at 10.1186/s13041-021-00848-w.
Databáze: OpenAIRE